<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04301583</url>
  </required_header>
  <id_info>
    <org_study_id>UEM004</org_study_id>
    <nct_id>NCT04301583</nct_id>
  </id_info>
  <brief_title>Procyanidin B2 Enriched Cocoa Effects on Mitochondrial Biogenesis</brief_title>
  <acronym>PROMETHEO</acronym>
  <official_title>Procyanidin B2 Enriched Cocoa Effects on Mitochondrial Biogenesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Europea de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Europea de Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test how cocoa-rich procyanidin B2 affect the mitochondrial
      exercise adaptations.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Sachets</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in mitochondrial number</measure>
    <time_frame>10 weeks</time_frame>
    <description>Number of mitochondria in blood cells measured by qPCR using mitochondrial COX1 gene and beta globin as housekeeping nuclear gene</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in exercise performance</measure>
    <time_frame>10 weeks</time_frame>
    <description>Maximum oxygen consumption
of incomplete pulmonary gas exchange on VO2 max - Powers - Citado por 318
determination of cardiorespiratory fitness and training … - Clark - Citado por 180 Maximum oxygen consumption</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Athletes</condition>
  <arm_group>
    <arm_group_label>Procyanidin B2 enriched cocoa</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receiving cocoa capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants maltodextrin capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>procyanidin B2 enriched cocoa</intervention_name>
    <description>Volunteers will intake 5 grams per day of dietary supplement for 10 weeks</description>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_label>Procyanidin B2 enriched cocoa</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men/Women

          -  Age between 18 and 45 years

          -  Aerobic power of oxygen consumption greater than or equal to 55 mL / kg / min

        Exclusion Criteria:

          -  Smoke

          -  Any chronic disease

          -  Intake of nutritional or ergogenic supplements

          -  Chronic medication

          -  Cocoa allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mar Larrosa</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Europea de Madrid</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad Europea de Madrid</name>
      <address>
        <city>Villaviciosa de Odón</city>
        <state>Madrid</state>
        <zip>28670</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 5, 2020</study_first_submitted>
  <study_first_submitted_qc>March 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2020</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Europea de Madrid</investigator_affiliation>
    <investigator_full_name>Mar Larrosa</investigator_full_name>
    <investigator_title>Tenure Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Proanthocyanidin</mesh_term>
    <mesh_term>Procyanidin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is not a plan to make IPD available</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

